Before you sell to, join or invest in Satellos Bioscience Inc.
MentionFox check on Satellos Bioscience Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/satellos-bioscience-inc-form-d-25000001
Check Satellos Bioscience Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Satellos Bioscience Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-03.
Satellos Bioscience Inc. filed a Form D notice of an exempt securities offering with the SEC on January 3, 2025. The filing reports $25.02M sold. Its industry group is Biotechnology. It names Frank Gleeson (Executive Officer, Director, Promoter), Michael Rudnicki (Executive Officer), Elizabeth Williams (Executive Officer) (SEC Form D, January 3, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Satellos Bioscience Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Satellos Bioscience Inc.
Free to see. No signup.
More on the people and the money behind Satellos Bioscience Inc., from the filings we hold.
Canaccord Genuity LLC received sales compensation on this raise and on 7 other raises we hold, nearest in date first:
Haywood Securities (USA) Inc. received sales compensation on this raise and on 4 other raises we hold, nearest in date first:
Get an email when Satellos Bioscience Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Satellos Bioscience Inc. raises, hires or launches. No email unless you switch it on.
Watch Satellos Bioscience Inc. →Get the full cited report on Satellos Bioscience Inc.
What the filing shows about Satellos Bioscience Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Satellos Bioscience Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Satellos Bioscience Inc.'s address as Royal Bank Plaza, S. Tower, 200 Bay St., Suite 2800, Toronto, A6 M5J 2J1.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Satellos Bioscience Inc. See pricing
Satellos Bioscience Inc. is a registered filer with the SEC (CIK 1421642) and has filed since 2023-05-25. 2 filings are on record, the latest on 2025-01-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Satellos Bioscience Inc.'s Form D of 2025-01-03 names Frank Gleeson, Michael Rudnicki, Elizabeth Williams and 11 more as its officers, directors or promoters.
Its new offerings report $58.31M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Frank Gleeson is named as Executive Officer and Director and Promoter on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Michael Rudnicki is named as Executive Officer on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Elizabeth Williams is named as Executive Officer on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Geoff MacKay is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Adam Mostafa is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Brian Bloom is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
William McVicar is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Bill Jarosz is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Rima Al-awar is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Michael Cross is named as Executive Officer on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Philip Lambert is named as Executive Officer on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Courtney Wells is named as Executive Officer on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Franklin Berger is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
Stephanie Brown is named as Director on the Form D that Satellos Bioscience Inc. filed with the SEC on 3 January 2025, one of 14 people that filing names.
14 people named on the filing — 6 holding an executive role and 8 as directors only.
Named as of the 2025-01-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 14 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Satellos Bioscience Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Satellos Bioscience Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Satellos Bioscience Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Satellos Bioscience Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Satellos Bioscience Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Satellos Bioscience Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/satellos-bioscience-inc-form-d-25000001